1393125-36-4

Basic information

• Product Name: (+/-)-tert-butyl 3-(N-tert-butyl-4-(1-hydroxy-3-methylbutyl)benzamido)propanoate
• Synonyms: (+/-)-tert-butyl 3-(N-tert-butyl-4-(1-hydroxy-3-methylbutyl)benzamido)propanoate
• CAS NO: 1393125-36-4
• Molecular Weight: 391.551
• Mol File: 1393125-36-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (+/-)-tert-butyl 3-(N-tert-butyl-4-(1-hydroxy-3-methylbutyl)benzamido)propanoate(CAS DataBase Reference)
• NIST Chemistry Reference: (+/-)-tert-butyl 3-(N-tert-butyl-4-(1-hydroxy-3-methylbutyl)benzamido)propanoate(1393125-36-4)
• EPA Substance Registry System: (+/-)-tert-butyl 3-(N-tert-butyl-4-(1-hydroxy-3-methylbutyl)benzamido)propanoate(1393125-36-4)

Safety Data

• Hazardous Substances Data: 1393125-36-4(Hazardous Substances Data)

Upstream product

• 118264-59-8 t-butyl 3-N-t-butylaminopropionate 
• 1393125-45-5 tert-butyl 3-(N-tert-butyl-4-formylbenzamido)propanoate 
• 926-62-5 isobutylmagnesium bromide 
• 619-66-9 4-Carboxybenzaldehyde 

Relevant articles and documents

GLUCAGON RECEPTOR MODULATORS

The present invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof wherein R1, R2, R3, A1, A2, A3, A4, L, B1, B2, B3 and B4 are as defined herein. The compounds of Formula I have been found to act as glucagon antagonists or inverse agonists. Consequently, the compounds of Formula I and the pharmaceutical compositions thereof are useful for the treatment of diseases, disorders, or conditions mediated by glucagon.